As new treatments, drugs and medical devices come to market the FDA is charged with making sure that they are both safe and perform as represented. Products that come under review include items such as human and animal drugs, blood and other biological products, medical devices, and foods. The process of evaluating these products has [...]
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) has announced a new phase I/II clinical trial of Apoptone (HE3235) for late stage prostate cancer. Howard Scher, M.D., Chief of the Genitourinary Oncology Service at Memorial Sloan-Kettering Cancer Center said "The preclinical data generated to date suggest that Apoptone may offer a unique therapeutic approach to late-stage prostate cancer where [...]
Life is tough enough with all of its twists and turns. We all experience hardships on our path, but we all also experience many pleasures and euphoric moments. Those of us who are under the influence of advanced prostate cancer still experience many moments of great pleasure and contentment. As a matter of fact, I [...]
Amgen just completed, with positive results, a three-year Phase 3 placebo-controlled trial which evaluated denosumab for the treatment of bone loss (reduction of bone mineral density –BMD) in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer. One of the more common and significant side effects of ADT is loss of BMD. This loss [...]
Have I been abandoned? I feel as if I have. In today’s mail was a letter from my kidney oncologist (I also have renal cancer) telling me that he will no longer accept my insurance! He said that he hoped that I would continue to use him as my physician, but if not he recommended [...]